Allison R. Ayala

ORCID: 0000-0002-1483-7536
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Retinal Diseases and Treatments
  • Glaucoma and retinal disorders
  • Corneal Surgery and Treatments
  • Retinal Development and Disorders
  • Corneal surgery and disorders
  • Retinal Imaging and Analysis
  • Ophthalmology and Visual Impairment Studies
  • Hearing, Cochlea, Tinnitus, Genetics
  • Ocular Surface and Contact Lens
  • Retinopathy of Prematurity Studies
  • Retinal and Optic Conditions
  • Ocular Diseases and Behçet’s Syndrome
  • RNA regulation and disease
  • CRISPR and Genetic Engineering
  • Ocular Disorders and Treatments
  • Nasal Surgery and Airway Studies
  • Ocular Infections and Treatments
  • bioluminescence and chemiluminescence research
  • Glutathione Transferases and Polymorphisms
  • Photoreceptor and optogenetics research
  • Intraocular Surgery and Lenses
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health and Medical Research Impacts
  • Sexual Differentiation and Disorders
  • Advanced Glycation End Products research

Jaeb Center for Health Research
2016-2025

Foundation Fighting Blindness
2022

University of Mississippi Medical Center
2019

Research Network (United States)
2016

SAS Institute (United States)
2016

National Eye Institute
2015

Eye Bank Association of America
2015

The prevalence of persistent diabetic macular edema (DME) after months anti-vascular endothelial growth factor therapy and its effect on visual acuity are unknown.

10.1001/jamaophthalmol.2015.5346 article EN JAMA Ophthalmology 2016-01-11

Purpose: The Foundation Fighting Blindness (FFB) Consortium is a collaboration of 41 international clinical centers that manage patients affected with inherited retinal diseases (IRDs). annual gene poll was initiated in 2020 to capture the genetic cause disease IRD and associated practices sites. Data from 2022 are reported here. Methods: In 2022, academic, private practice, government ophthalmology clinics members were polled identify per-case causality list 387 syndromic nonsyndromic...

10.1167/iovs.66.2.12 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2025-02-05

The aim of this study was to describe the aims, methods, donor and recipient cohort characteristics, potential impact Cornea Preservation Time Study (CPTS).The CPTS is a randomized clinical trial conducted at 40 sites (70 surgeons) designed assess effect cornea preservation time (PT) on graft survival 3 years after Descemet stripping automated endothelial keratoplasty (DSAEK). Eyes undergoing surgery for Fuchs corneal dystrophy or pseudophakic/aphakic edema were receive corneas stored ≤7...

10.1097/ico.0000000000000417 article EN cc-by-nc-nd Cornea 2015-04-08

To treat unilateral limbal stem cell (LSC) deficiency, we developed cultivated autologous epithelial cells (CALEC) using an innovative xenobiotic-free, serum-free, antibiotic-free, two-step manufacturing process for LSC isolation and expansion onto human amniotic membrane with rigorous quality control in a good practices facility. Limbal biopsies were used to generate CALEC constructs, final grafts evaluated by noninvasive scanning microscopy tested viability sterility. Cultivated maintained...

10.1126/sciadv.adg6470 article EN cc-by-nc Science Advances 2023-08-18

<h3>Importance</h3> Demonstrating that success of Descemet stripping automated endothelial keratoplasty is similar across donor cornea preservation times (PTs) could increase the pool. <h3>Objective</h3> To determine whether 3-year rate graft using corneal tissue preserved 8 to 14 days noninferior 7 or less. <h3>Design, Setting, and Participants</h3> A multicenter, double-masked, randomized noninferiority clinical trial was conducted from April 16, 2012, June 5, 2017, at 40 sites (70...

10.1001/jamaophthalmol.2017.4989 article EN JAMA Ophthalmology 2017-11-10

Demonstrating that endothelial cell loss following Descemet stripping automated keratoplasty (DSAEK) is independent of donor cornea preservation time (PT) could increase the pool corneal tissue available for keratoplasty.To determine whether 3 years after successful DSAEK related to PT.A multicenter, double-masked, randomized clinical trial included 40 sites (70 surgeons) in United States, with corneas provided by 23 US eye banks. A total 945 eyes 769 participants were Cornea Preservation...

10.1001/jamaophthalmol.2017.4970 article EN JAMA Ophthalmology 2017-11-10

Post hoc analyses from the Diabetic Retinopathy Clinical Research Network randomized clinical trial comparing aflibercept, bevacizumab, and ranibizumab for diabetic macular edema (DME) might influence interpretation of study results.

10.1001/jamaophthalmol.2016.3698 article EN JAMA Ophthalmology 2016-10-06

Purpose: The purpose of this study was to evaluate baseline best corrected visual acuity (BCVA), full-field electroretinography (ERG), stimulus thresholds (FST), and their relationship with demographic clinical characteristics in the Rate Progression Usher syndrome type 2 (USH2A)-related Retinal Degeneration (RUSH2A) multicenter study. Methods: Participants had (USH2, N = 80) or autosomal recessive nonsyndromic retinitis pigmentosa (ARRP, 47) associated biallelic variants USH2A gene....

10.1167/tvst.9.11.9 article EN cc-by-nc-nd Translational Vision Science & Technology 2020-10-08

Purpose: The purpose of this study was to evaluate self-reported functional vision (FV) and the impact loss in patients with USH2A-associated retinal degeneration using a patient-reported outcome (PRO) measure, Michigan Retinal Degeneration Questionnaire (MRDQ), correlate MRDQ scores well-established visual function measurements. Design: An observational cross-sectional (n = 93) participants who had Usher Syndrome Type 2 (USH2, n 55) or autosomal recessive non-syndromic retinitis pigmentosa...

10.1167/iovs.65.6.5 article EN cc-by-nc-nd Investigative Ophthalmology & Visual Science 2024-06-04

Purpose: To describe 1-year changes in the cornea as assessed by anterior segment optical coherence tomography (AS-OCT) and vivo confocal microscopy (IVCM) for participants receiving a tissue graft generated from new manufacturing process using cultivated autologous limbal epithelial cells. Methods: Cultivated cell grafts were produced 2-stage following good process-compliant protocol. AS-OCT IVCM completed at baseline 12 months after treatment subsets of these participants. Secondary...

10.1097/ico.0000000000003865 article EN Cornea 2025-03-28

<h3>Importance</h3> Determining factors associated with endothelial cell loss after Descemet stripping automated keratoplasty (DSAEK) could improve long-term graft survival. <h3>Objective</h3> To evaluate the associations of donor, recipient, and operative density (ECD) 3 years DSAEK in Cornea Preservation Time Study. <h3>Design, Setting, Participants</h3> This cohort study was a secondary analysis data collected multicenter, double-masked, randomized clinical trial. Forty US sites 70...

10.1001/jamaophthalmol.2018.5669 article EN JAMA Ophthalmology 2018-10-26

We assessed genotype-phenotype correlations among the visual, auditory, and olfactory phenotypes of 127 participants with Usher syndrome (USH2) (n =80) or nonsyndromic autosomal recessive retinitis pigmentosa (ARRP) = 47) due to USH2A variants, using clinical data molecular diagnostics from Rate Progression in Related Retinal Degeneration (RUSH2A) study. truncating alleles were associated USH2 had a dose-dependent effect on hearing loss severity no visual within subgroup. A group missense an...

10.1002/humu.24365 article EN Human Mutation 2022-03-10

Purpose: To assess donor rim culture results and outcomes of ocular infections in the Cornea Preservation Time Study (CPTS). Methods: Donor corneal cultures were optional. characteristics assessed for association with positive using Fisher exact test Poisson regression analyses. Incidence rates estimated, 95% confidence intervals calculated. Results: Cultures performed 784 (58.9%) 1330 cases. For 0 to 7-day versus 8 14-day preservation time groups, respectively, fungal growth occurred 10 397...

10.1097/ico.0000000000001654 article EN Cornea 2018-06-14

Optimization of glycemic control is critical to reduce the number diabetes mellitus-related complications, but long-term success challenging. Although vision loss among greatest fears individuals with diabetes, comprehensive personalized education and risk assessments are not consistently used in ophthalmologic settings.

10.1001/jamaophthalmol.2015.1312 article EN JAMA Ophthalmology 2015-05-21
Coming Soon ...